“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
On Jan. 4, 2023, the U.S. Transportation and Security Administration (TSA) extended its COVID-19 vaccine mandate for non-citizens and non-immigrants traveling to the United States by air until Apr. 10, 2023. The previous mandate expired on Jan. 9.1 The U.S is one of a few countries that require COVID vaccinations when flying into US airports without […]
During the peak of the COVID-19 pandemic, several countries in Africa were praised for controlling the pandemic by implementing traditional public health strategies to contain the spread of the SARS-CoV-2 virus, despite having underdeveloped and fragile public heath systems. With a population of more than one billion people, the African continent appears to have been […]
Nearly two years after the introduction of COVID-19 biologics around the world, the pharmaceutical industry is facing a waning demand for these products. Scott Rosenstein, a New York-based health care adviser to Eurasia Group said: Supply is exceeding demand in much of the world, even with many countries rolling out booster shots. Once the perception set […]
The number of previously healthy children younger than 16 years of age with mysterious hepatitis cases have doubled in two weeks to 450 cases worldwide, including 11 deaths. Most cases have been reported in the U.K. (160) and the U.S. (currently, 180). In Europe most cases are found in Italy (35) and Spain (22). Over 8-14 percent […]
“If only there were a message that could break through skepticism and persuade unvaccinated people to get their shots. What a world that would be. But over the past year, this really did happen,” reads a February 2022 Vox article1 that continues on to describe a Harvard Business School publication2 which offers new evidence on […]
Pfizer, Inc. has withdrawn its emergency use authorization (EUA) application for its experimental BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic (developed in collaboration with Germany’s BioNTech) in India.1 Pfizer was the first pharmaceutical company to apply for an EUA to distribute a COVID biologic in India in 2021. However, India’s regulatory agency […]
At the height of the fear and confusion associated with the declaration of a coronavirus pandemic public health emergency and strict social distancing regulations in the spring of 2020, U.S. health officials published a report that, in 2016, autism spectrum disorder (ASD) was estimated to affect one in 54 eight-year old children in the U.S., […]